Distribution of ganciclovir in the porcine central nervous system
Antimicrobial Agents and Chemotherapy · 2025
DOI: 10.1128/aac.01815-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Johan Mikkel Guldbæk und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, Aalborg University, Aalborg, North Denmark, Denmark. Hauptthemen laut MEDLINE: Ganciclovir, Antiviral Agents, Brain, Central Nervous System. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Fonden, Lions Clubs International Foundation.
Abstract (Originalsprache)
Ganciclovir is often used compassionately for encephalitis due to cytomegalovirus (CMV) and human herpes virus 6b (HHV-6b). Ganciclovir pharmacokinetic studies in the central nervous system (CNS) generally rely on single measurements in the cerebrospinal fluid (CSF) or homogenized brain tissue. Therefore the objective was to compare brain extracellular fluid (ECF) concentrations of ganciclovir with plasma and CSF concentrations in a porcine model, using microdialysis during a 24 h period. Six Danish landrace pigs (female, age 4 months, 31–37 kg) received two weight-adjusted intravenous doses of ganciclovir. Unbound ganciclovir concentrations were determined by microdialysis over 24 h in five compartments: CSF (lateral ventricle, cisterna magna, and lumbar) and brain ECF (cortical and subcortical). Data were compared with paired plasma samples. Ganciclovir concentrations >IC 50 for CMV (1.6 µg/mL) were achieved in all compartments. Concentrations >IC 90 for CMV (8.3 µg/mL) were only achieved in plasma and the lumbar CSF compartment. The concentration time curves indicated higher lumbar and cisternal CSF concentrations than ECF concentrations. The ECF compartments achieved greater maximum concentration (C max ), area under the concentration time curve (AUC), and time >IC 50 after the second dose, and an accumulation ratio (R ac ) >1. The greater C max , AUC, time >IC 50 , and R ac >1 in the ECF compartments with repeated dosages suggest that therapeutic concentrations may be achieved during long-term treatment. A higher loading dose might be warranted to improve early viral inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Medicine, Aalborg University, Aalborg, North Denmark, Denmark.
- Department of Infectious Diseases, Aalborg University Hospital, Aalborg, North Denmark, Denmark.
- ESCMID Study Group for Infectious Diseases of the Brain (ESGIB), Basel, Switzerland.
- Department of Neurosurgery, Aalborg University Hospital, Aalborg, North Denmark, Denmark.
- Institute of Neuropathology, University Medical Centre, Göttingen, Lower Saxony, Germany.
ORCID-Profile: Johan Mikkel Guldbæk, Theis Mariager, Roland Nau
Förderung
- Novo Nordisk Fonden
- Lions Clubs International Foundation
Zitieren
APA
Guldbæk, J. M., Mariager, T., Nielsen, M. D., Terkelsen, J. H., Nau, R., Bjarkam, C. R., Nielsen, H., & Bodilsen, J. (2025). Distribution of ganciclovir in the porcine central nervous system. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01815-24
Vancouver
Guldbæk JM, Mariager T, Nielsen MD, Terkelsen JH, Nau R, Bjarkam CR, et al. Distribution of ganciclovir in the porcine central nervous system. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01815-24
BibTeX
@article{Guldbk2025,
author = {Guldbæk, Johan Mikkel and Mariager, Theis and Nielsen, Mikkel Dreyer and Terkelsen, Jacob Holmen and Nau, Roland and Bjarkam, Carsten Reidies and Nielsen, Henrik and Bodilsen, Jacob},
title = {Distribution of ganciclovir in the porcine central nervous system},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
doi = {10.1128/aac.01815-24}
}
EUVIMED